72 related articles for article (PubMed ID: 8489735)
1. The usefulness of cell surface markers in predicting the prognosis of non-Hodgkin's lymphomas.
Baird S
Crit Rev Clin Lab Sci; 1993; 30(1):1-28. PubMed ID: 8489735
[TBL] [Abstract][Full Text] [Related]
2. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
[TBL] [Abstract][Full Text] [Related]
4. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
5. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
Glasová M; Koníková E; Stasáková J; Babusíková O
Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
Salter DM; Krajewski AS; Sheehan T; Turner G; Cuthbert RJ; Mclean A
J Pathol; 1989 Nov; 159(3):211-20. PubMed ID: 2593045
[TBL] [Abstract][Full Text] [Related]
7. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
8. [Non-Hodgkin's lymphoma and AIDS: histopathologic features].
Raphael M; Lamine M; Abd Alsamad I; Debré P; Binet JL
Arch Anat Cytol Pathol; 1992; 40(2-3):105-9. PubMed ID: 1449258
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
Kalyan K; Basu D; Soundararaghavan J
Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 14: a breakpoint in non-Hodgkin's lymphomas.
van 't Veer MB
Neth J Med; 1990 Aug; 37(1-2):37-43. PubMed ID: 2215832
[TBL] [Abstract][Full Text] [Related]
11. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
[TBL] [Abstract][Full Text] [Related]
12. [The clinical significance of the immunological phenotype in non-Hodgkin's lymphomas].
Golenkov AK; Miterev GIu; Popov VM; Shakher AL
Ter Arkh; 1995; 67(7):30-2. PubMed ID: 7482301
[TBL] [Abstract][Full Text] [Related]
13. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
14. [Flow cytometric analysis of surface phenotypes in B-cell non-Hodgkin's lymphoma].
Chubachi A
Rinsho Ketsueki; 1989 Dec; 30(12):2134-40. PubMed ID: 2516139
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.
Schuurman HJ; van Baarlen J; Huppes W; Lam BW; Verdonck LF; van Unnik JA
Am J Pathol; 1987 Oct; 129(1):140-51. PubMed ID: 3310650
[TBL] [Abstract][Full Text] [Related]
16. An overview of the classification of non-Hodgkin's lymphomas: an integration of morphological and phenotypical concepts.
Jaffe ES; Raffeld M; Medeiros LJ; Stetler-Stevenson M
Cancer Res; 1992 Oct; 52(19 Suppl):5447s-5452s. PubMed ID: 1394152
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
[TBL] [Abstract][Full Text] [Related]
18. [Histopathology of malignant lymphomas].
Yamabe H
Rinsho Byori; 1990 Apr; 38(4):386-9. PubMed ID: 2195192
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma.
Ong ST; Le Beau MM
Semin Oncol; 1998 Aug; 25(4):447-60. PubMed ID: 9728595
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
